Jonathan D. Powell

Active 1988–2025

89
Papers
23,015
Citations
74
h-index
89
i10-index

Citations

Citations per year for Jonathan D. Powell1988: 2 citations1989: 2 citations1990: 1 citations1992: 1 citations1994: 2 citations1998: 1 citations1999: 2 citations2000: 11 citations2001: 14 citations2002: 13 citations2003: 19 citations2004: 34 citations2005: 46 citations2006: 34 citations2007: 72 citations2008: 50 citations2009: 94 citations2010: 130 citations2011: 169 citations2012: 253 citations2013: 232 citations2014: 235 citations2015: 313 citations2016: 367 citations2017: 410 citations2018: 385 citations2019: 946 citations2020: 1,148 citations2021: 1,279 citations2022: 1,151 citations2023: 898 citations2024: 1,205 citations2025: 716 citations2026: 16 citations1991: no citations, so this year is not shown1993: no citations, so this year is not shown1995–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,562 citing papers, 29.8% of this breakdownChina: 2,076 citing papers, 17.4% of this breakdownGermany: 619 citing papers, 5.2% of this breakdownUnited Kingdom: 605 citing papers, 5% of this breakdownItaly: 528 citing papers, 4.4% of this breakdownFrance: 408 citing papers, 3.4% of this breakdownCanada: 358 citing papers, 3% of this breakdownJapan: 327 citing papers, 2.7% of this breakdownSpain: 272 citing papers, 2.3% of this breakdownAustralia: 261 citing papers, 2.2% of this breakdownNetherlands: 226 citing papers, 1.9% of this breakdownSwitzerland: 211 citing papers, 1.8% of this breakdown
0%29.8%Other 20.9%

Fields

  • Medicine39.5%
  • Biochemistry, Genetics and Molecular Biology27.2%
  • Immunology and Microbiology27%
  • Neuroscience2.5%
  • Engineering1.7%
  • Materials Science0.5%
  • Other1.6%

Topics

  • Immune Cell Function and Interaction9.7%
  • T-cell and B-cell Immunology5.6%
  • Cancer Immunotherapy and Biomarkers4.5%
  • Immune cells in cancer4.4%
  • Immunotherapy and Immune Responses3.6%
  • Cancer, Hypoxia, and Metabolism3.5%
  • Other68.7%

Coauthors

All papers

Open in search
  1. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion

    Authors: , , , , , , , , , , , , , , , , - Science 2019 cited by 1,177

  2. Metabolism of immune cells in cancer

    Authors: , - Nature reviews. Cancer 2020 cited by 864

  3. Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2020 cited by 433

  4. HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2008 cited by 1,906

  5. Role of LAG-3 in Regulatory T Cells

    Authors: , , , , , , , , , , , , , - Immunity 2004 cited by 1,299

  6. Developing a pro-regenerative biomaterial scaffold microenvironment requires T helper 2 cells

    Authors: , , , , , , , , , , , , , - Science 2016 cited by 632

  7. The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment

    Authors: , , , , , , , , - Immunity 2009 cited by 1,259

  8. Immune dysregulation as a driver of idiopathic pulmonary fibrosis

    Authors: , , , - Journal of Clinical Investigation 2021 cited by 293

  9. Regulation of Immune Responses by mTOR

    Authors: , , , - Annual Review of Immunology 2012 cited by 820

  10. An engineered IL-2 partial agonist promotes CD8+ T cell stemness

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature 2021 cited by 177

  11. Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug

    Authors: , , , , , , , , , , , , , , , , , , , - Science Advances 2022 cited by 124

  12. Targeting metabolism to regulate immune responses in autoimmunity and cancer

    Authors: , , , - Nature Reviews Drug Discovery 2019 cited by 319

  13. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2

    Authors: , , , , , , , , - Nature Immunology 2011 cited by 1,093

  14. mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation

    Authors: , , , , , , , - Journal of Clinical Investigation 2015 cited by 408

  15. Leucine Metabolism in T Cell Activation: mTOR Signaling and Beyond

    Authors: , , - Advances in Nutrition 2016 cited by 191

  16. Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models

    Authors: , , , , , , - Cancer Immunology Immunotherapy 2018 cited by 186

  17. mTOR, metabolism, and the regulation of T‐cell differentiation and function

    Authors: , - Immunological Reviews 2012 cited by 413

  18. Acid Suspends the Circadian Clock in Hypoxia through Inhibition of mTOR

    Authors: , , , , , , , , , , , , , , , , , - Cell 2018 cited by 235

  19. Hyaluronan Fragments Act as an Endogenous Danger Signal by Engaging TLR2

    Authors: , , , , , - The Journal of Immunology 2006 cited by 698

  20. RETRACTED ARTICLE: Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer

    Authors: , , , , , , , , , , , , , , , - Nature Communications 2022 cited by 97

  21. Antigen-driven EGR2 expression is required for exhausted CD8+ T cell stability and maintenance

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 59

  22. Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Phenotype

    Authors: , , , , , , , , - JAMA 2014 cited by 346

  23. Inhibition of the Adenosine Pathway to Potentiate Cancer Immunotherapy: Potential for Combinatorial Approaches

    Authors: , - Annual Review of Medicine 2020 cited by 76

  24. A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells

    Authors: , , , , , , , - Blood 2007 cited by 498